Heparin in experimental hyperdynamic sepsis

J. Meyer, C. S. Cox, David Herndon, H. Nakazawa, C. W. Lentz, L. D. Traber, D. L. Traber

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Objective: To evaluate the hypothesis that heparin administration increases cardiac output and improves oxygenation in experimental hyperdynamic sepsis in sheep. Design: Prospective trial. Setting: Laboratory at a large university-affiliated medical center. Subjects: A total of 14 sheep weighing 28 to 44 kg. Interventions: All 14 chronically instrumented sheep received a continuous infusion of Escherichia coli endotoxin (10 ng/kg/min) over 24 hrs. Seven sheep received a fixed bolus of beef lung heparin (5000 units) every 4 hrs intravenously. The other seven sheep served as controls. Measurements and Main Results: The heparinized animals showed a triphasic cardiovascular response. Cardiac index increased (p < .05), and systemic vascular resistance index decreased (p < .05) at 2 hrs after the start of the endotoxin infusion (early phase, 0 to 2 hrs). Both variables returned to approximately baseline levels at 4 hrs (second period, 2 to 4 hrs). A hyperdynamic state (in terms of an increased cardiac index), a decreased systemic vascular resistance index, and a decreased mean arterial pressure (MAP) (p <.05 for all) was observed in the third phase (8 to 24 hrs). In the control group, cardiac index, systemic vascular resistance index, and MAP showed no changes in the first period, but a slight decrease in cardiac index and a slight increase in systemic vascular resistance index in the second period. The onset of the hyperdynamic state was less pronounced in the control group and cardiac index was lower (p < .05); likewise, systemic vascular resistance index was increased (p < .05) when compared with heparinized animals. Both groups developed pulmonary hypertension during the endotoxin infusion. The gas exchange in the heparin group was significantly impaired in the first and second periods, but returned to baseline levels in the hyperdynamic phase, whereas the oxygenation of the nonheparinized animals showed only minor changes in the first and second phases, but deteriorated significantly during the third phase of endotoxemia. Conclusions: In this experimental model of hyperdynamic sepsis, heparin significantly influenced the cardiopulmonary performance. Heparin preserved gas exchange and increased cardiac output but lowered systemic vascular resistance and MAP in the hyperdynamic state.

Original languageEnglish (US)
Pages (from-to)84-89
Number of pages6
JournalCritical Care Medicine
Volume21
Issue number1
StatePublished - 1993

Fingerprint

Vascular Resistance
Heparin
Sepsis
Sheep
Arterial Pressure
Endotoxins
Cardiac Output
Gases
Control Groups
Endotoxemia
Pulmonary Hypertension
Theoretical Models
Lung

Keywords

  • blood pressure, hyperdynamic
  • cardiac output
  • critical illness
  • endotoxin
  • gas exchange
  • heparin
  • pulmonary
  • sepsis
  • septic shock
  • vascular resistance

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

Cite this

Meyer, J., Cox, C. S., Herndon, D., Nakazawa, H., Lentz, C. W., Traber, L. D., & Traber, D. L. (1993). Heparin in experimental hyperdynamic sepsis. Critical Care Medicine, 21(1), 84-89.

Heparin in experimental hyperdynamic sepsis. / Meyer, J.; Cox, C. S.; Herndon, David; Nakazawa, H.; Lentz, C. W.; Traber, L. D.; Traber, D. L.

In: Critical Care Medicine, Vol. 21, No. 1, 1993, p. 84-89.

Research output: Contribution to journalArticle

Meyer, J, Cox, CS, Herndon, D, Nakazawa, H, Lentz, CW, Traber, LD & Traber, DL 1993, 'Heparin in experimental hyperdynamic sepsis', Critical Care Medicine, vol. 21, no. 1, pp. 84-89.
Meyer J, Cox CS, Herndon D, Nakazawa H, Lentz CW, Traber LD et al. Heparin in experimental hyperdynamic sepsis. Critical Care Medicine. 1993;21(1):84-89.
Meyer, J. ; Cox, C. S. ; Herndon, David ; Nakazawa, H. ; Lentz, C. W. ; Traber, L. D. ; Traber, D. L. / Heparin in experimental hyperdynamic sepsis. In: Critical Care Medicine. 1993 ; Vol. 21, No. 1. pp. 84-89.
@article{5db240fe16b34d17b1da770f4fd9c9b5,
title = "Heparin in experimental hyperdynamic sepsis",
abstract = "Objective: To evaluate the hypothesis that heparin administration increases cardiac output and improves oxygenation in experimental hyperdynamic sepsis in sheep. Design: Prospective trial. Setting: Laboratory at a large university-affiliated medical center. Subjects: A total of 14 sheep weighing 28 to 44 kg. Interventions: All 14 chronically instrumented sheep received a continuous infusion of Escherichia coli endotoxin (10 ng/kg/min) over 24 hrs. Seven sheep received a fixed bolus of beef lung heparin (5000 units) every 4 hrs intravenously. The other seven sheep served as controls. Measurements and Main Results: The heparinized animals showed a triphasic cardiovascular response. Cardiac index increased (p < .05), and systemic vascular resistance index decreased (p < .05) at 2 hrs after the start of the endotoxin infusion (early phase, 0 to 2 hrs). Both variables returned to approximately baseline levels at 4 hrs (second period, 2 to 4 hrs). A hyperdynamic state (in terms of an increased cardiac index), a decreased systemic vascular resistance index, and a decreased mean arterial pressure (MAP) (p <.05 for all) was observed in the third phase (8 to 24 hrs). In the control group, cardiac index, systemic vascular resistance index, and MAP showed no changes in the first period, but a slight decrease in cardiac index and a slight increase in systemic vascular resistance index in the second period. The onset of the hyperdynamic state was less pronounced in the control group and cardiac index was lower (p < .05); likewise, systemic vascular resistance index was increased (p < .05) when compared with heparinized animals. Both groups developed pulmonary hypertension during the endotoxin infusion. The gas exchange in the heparin group was significantly impaired in the first and second periods, but returned to baseline levels in the hyperdynamic phase, whereas the oxygenation of the nonheparinized animals showed only minor changes in the first and second phases, but deteriorated significantly during the third phase of endotoxemia. Conclusions: In this experimental model of hyperdynamic sepsis, heparin significantly influenced the cardiopulmonary performance. Heparin preserved gas exchange and increased cardiac output but lowered systemic vascular resistance and MAP in the hyperdynamic state.",
keywords = "blood pressure, hyperdynamic, cardiac output, critical illness, endotoxin, gas exchange, heparin, pulmonary, sepsis, septic shock, vascular resistance",
author = "J. Meyer and Cox, {C. S.} and David Herndon and H. Nakazawa and Lentz, {C. W.} and Traber, {L. D.} and Traber, {D. L.}",
year = "1993",
language = "English (US)",
volume = "21",
pages = "84--89",
journal = "Critical Care Medicine",
issn = "0090-3493",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Heparin in experimental hyperdynamic sepsis

AU - Meyer, J.

AU - Cox, C. S.

AU - Herndon, David

AU - Nakazawa, H.

AU - Lentz, C. W.

AU - Traber, L. D.

AU - Traber, D. L.

PY - 1993

Y1 - 1993

N2 - Objective: To evaluate the hypothesis that heparin administration increases cardiac output and improves oxygenation in experimental hyperdynamic sepsis in sheep. Design: Prospective trial. Setting: Laboratory at a large university-affiliated medical center. Subjects: A total of 14 sheep weighing 28 to 44 kg. Interventions: All 14 chronically instrumented sheep received a continuous infusion of Escherichia coli endotoxin (10 ng/kg/min) over 24 hrs. Seven sheep received a fixed bolus of beef lung heparin (5000 units) every 4 hrs intravenously. The other seven sheep served as controls. Measurements and Main Results: The heparinized animals showed a triphasic cardiovascular response. Cardiac index increased (p < .05), and systemic vascular resistance index decreased (p < .05) at 2 hrs after the start of the endotoxin infusion (early phase, 0 to 2 hrs). Both variables returned to approximately baseline levels at 4 hrs (second period, 2 to 4 hrs). A hyperdynamic state (in terms of an increased cardiac index), a decreased systemic vascular resistance index, and a decreased mean arterial pressure (MAP) (p <.05 for all) was observed in the third phase (8 to 24 hrs). In the control group, cardiac index, systemic vascular resistance index, and MAP showed no changes in the first period, but a slight decrease in cardiac index and a slight increase in systemic vascular resistance index in the second period. The onset of the hyperdynamic state was less pronounced in the control group and cardiac index was lower (p < .05); likewise, systemic vascular resistance index was increased (p < .05) when compared with heparinized animals. Both groups developed pulmonary hypertension during the endotoxin infusion. The gas exchange in the heparin group was significantly impaired in the first and second periods, but returned to baseline levels in the hyperdynamic phase, whereas the oxygenation of the nonheparinized animals showed only minor changes in the first and second phases, but deteriorated significantly during the third phase of endotoxemia. Conclusions: In this experimental model of hyperdynamic sepsis, heparin significantly influenced the cardiopulmonary performance. Heparin preserved gas exchange and increased cardiac output but lowered systemic vascular resistance and MAP in the hyperdynamic state.

AB - Objective: To evaluate the hypothesis that heparin administration increases cardiac output and improves oxygenation in experimental hyperdynamic sepsis in sheep. Design: Prospective trial. Setting: Laboratory at a large university-affiliated medical center. Subjects: A total of 14 sheep weighing 28 to 44 kg. Interventions: All 14 chronically instrumented sheep received a continuous infusion of Escherichia coli endotoxin (10 ng/kg/min) over 24 hrs. Seven sheep received a fixed bolus of beef lung heparin (5000 units) every 4 hrs intravenously. The other seven sheep served as controls. Measurements and Main Results: The heparinized animals showed a triphasic cardiovascular response. Cardiac index increased (p < .05), and systemic vascular resistance index decreased (p < .05) at 2 hrs after the start of the endotoxin infusion (early phase, 0 to 2 hrs). Both variables returned to approximately baseline levels at 4 hrs (second period, 2 to 4 hrs). A hyperdynamic state (in terms of an increased cardiac index), a decreased systemic vascular resistance index, and a decreased mean arterial pressure (MAP) (p <.05 for all) was observed in the third phase (8 to 24 hrs). In the control group, cardiac index, systemic vascular resistance index, and MAP showed no changes in the first period, but a slight decrease in cardiac index and a slight increase in systemic vascular resistance index in the second period. The onset of the hyperdynamic state was less pronounced in the control group and cardiac index was lower (p < .05); likewise, systemic vascular resistance index was increased (p < .05) when compared with heparinized animals. Both groups developed pulmonary hypertension during the endotoxin infusion. The gas exchange in the heparin group was significantly impaired in the first and second periods, but returned to baseline levels in the hyperdynamic phase, whereas the oxygenation of the nonheparinized animals showed only minor changes in the first and second phases, but deteriorated significantly during the third phase of endotoxemia. Conclusions: In this experimental model of hyperdynamic sepsis, heparin significantly influenced the cardiopulmonary performance. Heparin preserved gas exchange and increased cardiac output but lowered systemic vascular resistance and MAP in the hyperdynamic state.

KW - blood pressure, hyperdynamic

KW - cardiac output

KW - critical illness

KW - endotoxin

KW - gas exchange

KW - heparin

KW - pulmonary

KW - sepsis

KW - septic shock

KW - vascular resistance

UR - http://www.scopus.com/inward/record.url?scp=0027399872&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027399872&partnerID=8YFLogxK

M3 - Article

C2 - 8420736

AN - SCOPUS:0027399872

VL - 21

SP - 84

EP - 89

JO - Critical Care Medicine

JF - Critical Care Medicine

SN - 0090-3493

IS - 1

ER -